We have previously shown that icaritin can effectively inhibit chronic myeloid leukemia (CML) cells growth and induce CML cells apoptosis via the mechanisms involved in MAPK/ERK/JNK and JAK2/STAT3/AKT signaling [10]. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.